RNLX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 120212 min ago

@ $1.190

Wydano: 14 vas. 2024 @ 22:54

Zwrot: -41.92%

Poprzedni sygnał: vas. 14 - 20:31

Poprzedni sygnał: Kupno

Zwrot: 3.48 %

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	234 811
Średni wolumen	1.98M
Kapitalizacja rynkowa	53.34M
EPS	$-0.110 ( 2023-11-14 )
Następna data zysków	( $-0.0800 ) 2024-06-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.770
ATR14	$0.00200 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Icahn School Of Medicine At Mount Sinai	Buy	9 360 374	Ordinary Shares
2023-11-20	Coste Catherine	Buy	95 000	Employee Stock Option (right to buy)
2023-11-20	Levangie Daniel J	Buy	95 000	Employee Stock Option (right to buy)
2023-11-20	Parikh Chirag R.	Buy	95 000	Employee Stock Option (right to buy)
2023-11-20	Mills Christopher	Buy	95 000	Employee Stock Option (right to buy)

INSIDER POWER
84.35
Last 27 transactions
Buy: 12 713 670 \| Sell: 1 641 743

Wolumen Korelacja

Długi: 0.15 (neutral)

Krótki: -0.38 (neutral)

Signal:(43.903) Neutral

Renalytix AI plc Korelacja

10 Najbardziej pozytywne korelacje
PUCK	0.925
NVCN	0.921
TWLV	0.92
TWCB	0.92
KSICU	0.919
GXII	0.918
OVID	0.917
UBFO	0.916
TBLA	0.915
KVSA	0.914

10 Najbardziej negatywne korelacje
AMGN	-0.943
NAKD	-0.921
CYTO	-0.921
AHPI	-0.913
HCAQ	-0.909
PROC	-0.905
LAWS	-0.905
THMA	-0.896
PCSA	-0.894
LSAQ	-0.892

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Renalytix AI plc Korelacja - Waluta/Towar

0.05
( neutral )

0.00
( neutral )

-0.55
( weak negative )

0.00
( neutral )

-0.35
( neutral )

Renalytix AI plc Finanse

Annual	2023
Przychody:	$3.40M
Zysk brutto:	$701 000 (20.60 %)
EPS:	$-1.120

FY	2023
Przychody:	$3.40M
Zysk brutto:	$701 000 (20.60 %)
EPS:	$-1.120

FY	2022
Przychody:	$2.97M
Zysk brutto:	$918 000 (30.91 %)
EPS:	$-1.560

FY	2021
Przychody:	$1.49M
Zysk brutto:	$633 000 (42.45 %)
EPS:	$-0.860

Financial Reports:

No articles found.

Renalytix AI plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.